Root Financial Partners’s Rigel Pharmaceuticals RIGL Stock Holding History

Root Financial Partners’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.26K	Buy	+47	New	+$2.04K	﹤0.01%	2589

Other funds holding RIGL

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Root Financial Partners's RIGL Position: Q3 2026 in Review

Root Financial Partners opened a new position in Rigel Pharmaceuticals (RIGL) in Q3 2026: 47 shares worth $2.26K. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings.

127 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

Root Financial Partners held 47 shares of Rigel Pharmaceuticals worth $2.26K as of Q3 2026.
Rigel Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
Rigel Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #2589 holding.
127 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.